The Drug Enforcement Administration (DEA) has released a list of a few malaria drugs that the agency is now monitoring.
The list, which was released by the DEA, includes two new malaria drugs.
The first is a drug called Malaria B, which has been on the market since 2013 and is a non-psychoactive formulation of the drug malaria b, according to the agency.
It was first approved by the FDA in 2018, and its active ingredient is a form of malaria toxin, the agency said.
It is currently on the markets of a number of countries including China, India, Vietnam, Nigeria, and South Africa.
The second new malaria drug, Malaria C, is currently in the investigational stage, according the DEA.
It contains the same active ingredient as the first drug but it has been shown to have fewer side effects, according Toomey.
It can be administered as a shot, a pill, or a tablet, the DEA said.
Malaria A, also known as malaria b, is a newer malaria drug that has been approved by two different countries, India and South Korea.
The drug was approved by both countries in 2019 and was shown to be less toxic and less likely to cause severe side effects than the drug that the FDA approved in 2018.
The DEA said Malaria H, which is currently undergoing testing in the U.S., is an investigational drug that is currently being evaluated for safety and efficacy.
MalaB has been developed by Pfizer, which makes the drug.
The agency said the drug was evaluated for efficacy against malaria in humans and has not yet been approved for sale in the United States.
In the meantime, the U,S.
has seen more cases of malaria.
Between January and July this year, there were 6,938 cases of the disease in the US, according Dr. Andrew D. Schlosser, the assistant secretary for public affairs and emergency preparedness at the DEA who said the numbers are expected to climb further.
He said the U.,S.
reported more than 1,500 new malaria cases in August, which the agency attributed to an increase in the number of new cases of infection due to the global pandemic.
More than 5,000 Americans died from malaria in the first five months of 2017, according data from the Centers for Disease Control and Prevention (CDC).